JNK and Macroautophagy Activation by Bortezomib Has a Pro-Survival Effect in Primary Effusion Lymphoma Cells-Reference-Cited by-同舟云学术

JNK and Macroautophagy Activation by Bortezomib Has a Pro-Survival Effect in Primary Effusion Lymphoma Cells

Published:2013-09-26 Issue:9 Volume:8 Page:e75965
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Granato Marisa,Santarelli Roberta,Lotti Lavinia V.,Di Renzo Livia,Gonnella Roberta,Garufi Alessia,Trivedi Pankaj,Frati Luigi,D’Orazi Gabriella,Faggioni Alberto,Cirone Mara

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus;RG Nador;Blood,1996

2. Primary effusion lymphoma cell death induced by bortezomib and AG 490 activates dendritic cells through CD91;M Cirone;PLoS One,2012

3. The proteasome inhibitor bortezomib (PS-341) inhibits growth and induces apoptosis in primary effusion lymphoma cells;H Matta;Cancer Biol Ther,2005

4. Proteasome inhibition and its therapeutic potential in multiple myeloma;A Chari;Biologics,2010

5. Linking ER Stress to Autophagy: Potential Implications for Cancer Therapy;T Verfaillie;Int J Cell Biol,2010

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of programmed cell death in osteosarcoma: From pathogenesis to therapy;Cancer Medicine;2024-05

2. The ERK1/2-Elk1, JNK-cJun, and JAK-STAT Transcriptional Axes as Potential Bortezomib Resistance Mediators in Prostate Cancer;2024-04-20

3. ATF6 supports lysosomal function in tumor cells to enable ER stress-activated macroautophagy and CMA: impact on mutant TP53 expression;Autophagy;2024-04-09

4. New insights into the Bortezomib‐induced cytotoxic and resistance mechanisms in a primary effusion lymphoma mouse model;Hematological Oncology;2024-03

5. JQ-1/bortezomib combination strongly impairs MM and PEL survival by inhibiting c-Myc and mTOR despite the activation of prosurvival mechanisms;Experimental Hematology;2023-03